Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

18.61USD
15 Dec 2017
Change (% chg)

$1.31 (+7.57%)
Prev Close
$17.30
Open
$17.75
Day's High
$18.65
Day's Low
$17.51
Volume
11,466,653
Avg. Vol
4,720,074
52-wk High
$38.30
52-wk Low
$10.85

Chart for

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 0.50
Market Cap(Mil.): $18,265.35
Shares Outstanding(Mil.): 1,014.36
Dividend: 0.09
Yield (%): 4.57

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

Strike over Teva Pharm job cuts briefly shuts down Israel

JERUSALEM Israel's main public-sector labor union staged a half-day strike on Sunday, closing the airport, stock exchange, banks and all government ministries to protest at mass layoffs planned by Teva Pharmaceutical Industries .

10:21am EST

UPDATE 2-Strike over Teva Pharm job cuts briefly shuts down Israel

JERUSALEM, Dec 17 Israel's main public-sector labour union staged a half-day strike on Sunday, closing the airport, stock exchange, banks and all government ministries to protest at mass layoffs planned by Teva Pharmaceutical Industries.

10:18am EST

Strike briefly shuts down Israel over Teva Pharm job cuts

JERUSALEM, Dec 17 Israel's main public-sector labour union went on a half-day strike on Sunday, closing the airport, the stock exchange, banks and all government ministries as part of a protest against mass layoffs planned by Teva Pharmaceutical Industries.

3:09am EST

EU mergers and takeovers (Dec 15)

BRUSSELS, Dec 15 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Dec 15 2017

BRIEF-Teva Announces Exclusive Launch Of Generic Viread® In The United States

* TEVA ANNOUNCES EXCLUSIVE LAUNCH OF GENERIC VIREAD® IN THE UNITED STATES

Dec 15 2017

Teva Pharm to lay off a quarter of workforce, suspends dividend

TEL AVIV Teva Pharmaceutical Industries is to cut its workforce by more than a quarter, give up many of its manufacturing plants and suspend its dividend on ordinary shares in a much-anticipated overhaul to help pay off its debts.

Dec 14 2017

UPDATE 3-Teva Pharm to lay off a quarter of workforce, suspends dividend

* Teva to take restructuring charge of at least $700 mln in 2018

Dec 14 2017

BRIEF-Teva Pharm CEO says cost-cutting won't hurt competitiveness

* TEVA PHARM CEO: EXPECTS U.S. GENERIC PRICES OVERALL TO FALL IN 2018

Dec 14 2017

BRIEF-Teva Pharm CEO says company does not plan to raise equity

* TEVA PHARM CEO: WILL USE CASH FLOW TO PAY DOWN DEBT IN COMING YEARS, INITIALLY WILL FOCUS ON BANK DEBT

Dec 14 2017

BRIEF-Teva Announces Restructuring Plan And Measures To Improve Its Business And Financial Performance

* TEVA ANNOUNCES RESTRUCTURING PLAN AND ADDITIONAL MEASURES TO IMPROVE ITS BUSINESS AND FINANCIAL PERFORMANCE

Dec 14 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.80 -0.05
Biogen Inc (BIIB.OQ) $327.94 +4.39

Earnings vs. Estimates